Your browser doesn't support javascript.
loading
[Pheochromocytoma and paraganglioma: basics for the general practitioner]. / Phéochromocytome et paragangliome: que doit retenir le praticien?
Rev Med Suisse ; 10(441): 1650-2, 1654-5, 2014 Sep 10.
Article en Fr | MEDLINE | ID: mdl-25322623
ABSTRACT
Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors secreting catecholamines in most cases. The clinic can be very variable. Morbidity and mortality PHEO and PGL are primarily cardiovascular and haves catecholamine-mediated origin. The PHEO and PGL can sign in with a syndromic association with multiple tumors and genetic counseling is necessary in search of a germline mutation. The first step includes a diagnostic assay of metanephrine and normetanephrines. In case of positive biology a CT or MRI imaging will be needed to locate the tumor. Treatment with alpha-blocker before surgery reduces the perioperative risk. A long term follow up is recommended to detect recurrence.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Límite: Humans / Male / Middle aged Idioma: Fr Revista: Rev Med Suisse Asunto de la revista: MEDICINA Año: 2014 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Límite: Humans / Male / Middle aged Idioma: Fr Revista: Rev Med Suisse Asunto de la revista: MEDICINA Año: 2014 Tipo del documento: Article